During this presentation we welcome, Jaguar Health. Jaguar Health (Nasdaq: JAGX) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain.

This Company Webcast was recorded during the Lytham Partners Fall 2024 Investor Conference.